ELI LILLY & Co is 3.7x more valuable than AstraZeneca PLC by market capitalization ($1.072 T vs $286.27 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | LLY | AZN |
|---|---|---|
| Market cap | $1.072 T | $286.27 B |
| US-listed rank | #10 | #45 |
| Revenue (latest FY) | $65.18B | - |
| Net income (latest FY) | $20.64B | - |
| Net margin | 31.7% | - |
| P/E (trailing FY) | 51.9 | - |
| SEC filings | 989 | 1,004 |
ELI LILLY & Co is 3.7x more valuable than AstraZeneca PLC by market capitalization ($1.072 T vs $286.27 B).
Full pages: ELI LILLY & Co and AstraZeneca PLC, or browse the full rankings.